Isolation of poliovirus shedding following vaccination in children with antibody deficiency disorders

Journal of Infection in Developing Countries

Volumn 6, Issue 12, 2012, Pages 881-885

  Galal, Nermeen M ^a   Bassiouny, Laila ^b   Nasr, Eman ^b   Abdelmeguid, Naglaa ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Poliomyelitis; Primary immunodeficiency; Prolonged shedding

Indexed keywords

IMMUNOGLOBULIN; ORAL POLIOMYELITIS VACCINE;

AGAMMAGLOBULINEMIA; ARTICLE; ATAXIA TELANGIECTASIA; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEFICIENCY; MALE; NUCLEOTIDE SEQUENCE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEROTYPING; VACCINATION; VIRUS SHEDDING;

EID: 84876275114     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2372     Document Type: Article

References (20)

1. Yang C, Chen H, Jorba J Sun HC, Yang SJ, Lee HC, Huang YC, Lin TY, Chen PJ, Shimizu H, Nishimura Y, Utama A, Pallansch M, Miyamura T, Kew O, Yang JY (2005) Intratypic recombination among lineages of type 1 vaccine derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 79: 12623-12634.
2. Sutter RW, Kew OM, Cochi SL (2003) Poliovirus Vaccine.In Plotkin SA and Orenstein WA, editors.Vaccines. 4th ed. Philadelphia: W.B. Saunders Company. 651-705.
3. Bellmunt A, May G, Zell R, Pring-Akerblom P, Verhagen W, Heim A (1999) Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265: 178-184.
4. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59: 587-635.
5. Kew OM, Sutter RW, Nottay B, McDonough M, Prevots DR, Quick L, Pallansch M (1998) Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 36: 2893-2899.
6. Martin J, Dunn G, Hull R, Patel V, Minor (2000) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74: 3001-3010.
7. Yoneyama T, Hagiwara A, Hara M, Shimojo (1982) Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients. Infect Immun 37: 46-53.
8. Halsey N, Pinto J, Espinosa-Rosales F, Faurie-Fontenla M, da Silva E, Khan A, Webster A, Minor P, Dunn G, Austrias E, Hussain H, Pallansch M, Kew M, Winkelstein J, Sutter R (2004) Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ vol.82 no.1 Geneva.
9. Geha RS, Notarangelo LD, Casanova JL (2007) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120: 776-794.
10. World Health Organization (2004). Polio laboratory manual, 4th edition. Geneva: World Health Organization. (WHO/EPI/GEN/97.01) Ordering code: WHO/IVB/04.10.
11. Hidalgo S (2003) Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child Pediatr Infect Dis J 22: 570-572.
12. Odoom JK (2008) Changes in population dynamics during long-term evolution of sabin type 1poliovirus in an immunodeficient patient J Virol 82: 9179-9190.
13. Buttinelli G, Donati V, Fiore S, Marturano J, Plebani A, Balestri P, Soresina AR, Vivarelli R, Delpeyroux F, Martin J, Fiore L (2003) Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis J Gen Virol 84: 1215-1221.
14. Khetsuriani N (2009) Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya, BMC Infect Dis 9: 136-139.
15. Hennessey KA (2005) Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire J Infect Dis 192: 2124-2128.
16. Asturias EJ (2006) Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer. Biologicals 34: 109-12.
17. Barbouche MR, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, Bejaoui M, Boutros J, Marsafy A, Bousfiha AA (2011) Primary immunodeficiencies in highly consanguineous North African populations. Ann NY Acad Sci 1238: 42-52.
18. Gathmann B, Grimbacher B, Beaute J, Dudoit J, Mahlaoui N, Fischer A, Knerr V, Kindle G, ESID Working Party (2009) The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clinical and Experimental Immunology 157: 3-11.
19. Reda S, Afifi H, Amine M (2009) Primary Immunodeficiency Diseases in Egyptian Children: A Single-Center Study J Clin Immunol 29: 343-351.
20. Cunningham-Rundles C and Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clinical Immunology 92: 34-48.